Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma

Daphne C Richter1, James R Joubert1, Haylene Nell1, Mace M Schuurmans2, Elvis M Irusen21Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, RSA; 2Respiratory Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of Stellenbosch, RSAObjective: The GOLD guidelines...

Full description

Bibliographic Details
Main Authors: Daphne C Richter, James R Joubert, Haylene Nell, Mace M Schuurmans, Elvis M Irusen
Format: Article
Language:English
Published: Dove Medical Press 2008-11-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/diagnostic-value-of-post-bronchodilator-pulmonary-function-testing-to--a2547
id doaj-ffc9f842e7cb4f0c98108b69739cabff
record_format Article
spelling doaj-ffc9f842e7cb4f0c98108b69739cabff2020-11-25T00:07:21ZengDove Medical PressInternational Journal of COPD1176-91061178-20052008-11-012008Issue 4693699Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthmaDaphne C RichterJames R JoubertHaylene NellMace M SchuurmansElvis M IrusenDaphne C Richter1, James R Joubert1, Haylene Nell1, Mace M Schuurmans2, Elvis M Irusen21Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, RSA; 2Respiratory Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of Stellenbosch, RSAObjective: The GOLD guidelines suggest that the presence of a post-bronchodilator forced expiratory volume in one second (FEV1) 80% of the predicted value in combination with a FEV1/forced vital capacity (FVC) < 70% confirms the diagnosis of COPD. Limited data exist regarding the accuracy of these criteria to distinguish between COPD and asthma. The aim of this study therefore was to investigate the diagnostic value of post-bronchodilator lung function parameters in obstructive lung disease.Methods: The pulmonary function tests of 43 (22 = COPD, 21 = asthma) patients with similar baseline characteristics were evaluated (baseline FEV1 were 55.7% + 7.6%, and 59.3% + 8.4% predicted for COPD and asthma, respectively). Bronchodilator responsiveness (BDR) was calculated according to three recognized pulmonary function test criteria.Results: The first criteria, post-bronchodilator FEV1 < 80% of the predicted value in combination with a post-bronchodilator FEV1/FVC ratio of <70%, had an accuracy of 70% to diagnose COPD. This combination was very sensitive (100%) in diagnosing COPD, but it was not specific (38%). The second BDR criteria, defined as an increase of <12% and 200 mL of initial FEV1 and criterion number 3, an increase of <9% of predicted FEV1, were less sensitive (55% and 59%, respectively), but more specific (81% and 76% respectively) to diagnose COPD. Our findings suggest that the current recommended spirometric indices are not optimal in differentiating between COPD and asthma.Keywords: obstructive lung disease, diagnosis, post-bronchodilator pulmonary function test http://www.dovepress.com/diagnostic-value-of-post-bronchodilator-pulmonary-function-testing-to--a2547
collection DOAJ
language English
format Article
sources DOAJ
author Daphne C Richter
James R Joubert
Haylene Nell
Mace M Schuurmans
Elvis M Irusen
spellingShingle Daphne C Richter
James R Joubert
Haylene Nell
Mace M Schuurmans
Elvis M Irusen
Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
International Journal of COPD
author_facet Daphne C Richter
James R Joubert
Haylene Nell
Mace M Schuurmans
Elvis M Irusen
author_sort Daphne C Richter
title Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
title_short Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
title_full Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
title_fullStr Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
title_full_unstemmed Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
title_sort diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe copd and asthma
publisher Dove Medical Press
series International Journal of COPD
issn 1176-9106
1178-2005
publishDate 2008-11-01
description Daphne C Richter1, James R Joubert1, Haylene Nell1, Mace M Schuurmans2, Elvis M Irusen21Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, RSA; 2Respiratory Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of Stellenbosch, RSAObjective: The GOLD guidelines suggest that the presence of a post-bronchodilator forced expiratory volume in one second (FEV1) 80% of the predicted value in combination with a FEV1/forced vital capacity (FVC) < 70% confirms the diagnosis of COPD. Limited data exist regarding the accuracy of these criteria to distinguish between COPD and asthma. The aim of this study therefore was to investigate the diagnostic value of post-bronchodilator lung function parameters in obstructive lung disease.Methods: The pulmonary function tests of 43 (22 = COPD, 21 = asthma) patients with similar baseline characteristics were evaluated (baseline FEV1 were 55.7% + 7.6%, and 59.3% + 8.4% predicted for COPD and asthma, respectively). Bronchodilator responsiveness (BDR) was calculated according to three recognized pulmonary function test criteria.Results: The first criteria, post-bronchodilator FEV1 < 80% of the predicted value in combination with a post-bronchodilator FEV1/FVC ratio of <70%, had an accuracy of 70% to diagnose COPD. This combination was very sensitive (100%) in diagnosing COPD, but it was not specific (38%). The second BDR criteria, defined as an increase of <12% and 200 mL of initial FEV1 and criterion number 3, an increase of <9% of predicted FEV1, were less sensitive (55% and 59%, respectively), but more specific (81% and 76% respectively) to diagnose COPD. Our findings suggest that the current recommended spirometric indices are not optimal in differentiating between COPD and asthma.Keywords: obstructive lung disease, diagnosis, post-bronchodilator pulmonary function test
url http://www.dovepress.com/diagnostic-value-of-post-bronchodilator-pulmonary-function-testing-to--a2547
work_keys_str_mv AT daphnecrichter diagnosticvalueofpostbronchodilatorpulmonaryfunctiontestingtodistinguishbetweenstablemoderatetoseverecopdandasthma
AT jamesrjoubert diagnosticvalueofpostbronchodilatorpulmonaryfunctiontestingtodistinguishbetweenstablemoderatetoseverecopdandasthma
AT haylenenell diagnosticvalueofpostbronchodilatorpulmonaryfunctiontestingtodistinguishbetweenstablemoderatetoseverecopdandasthma
AT macemschuurmans diagnosticvalueofpostbronchodilatorpulmonaryfunctiontestingtodistinguishbetweenstablemoderatetoseverecopdandasthma
AT elvismirusen diagnosticvalueofpostbronchodilatorpulmonaryfunctiontestingtodistinguishbetweenstablemoderatetoseverecopdandasthma
_version_ 1725418764427591680